Merck KGaA announced that it has entered into a definitive agreement to acquire the microbiology business of Biotest AG. The business has approximately 290 employees and sales of approximately €50 million in 2010.
Senectus Therapeutics has signed a deal to screen a selection of AstraZeneca’s chemical compound library to identify those which trigger a key element of cancer cell ageing – called senescence.
Provectus Pharmaceuticals, Inc. has held its second end-of-Phase 2 meeting with the U.S. Food and Drug Administration. The meeting addressed the company’s planned pivotal Phase 3 randomized controlled trial of PV-10 for metastatic melanoma.
Bristol-Myers Squibb Co. said that a new study of its highly anticipated melanoma drug improved survival time in patients with advanced skin cancer.
Cephalon Inc. said it will acquire privately held Gemin X Pharmaceuticals Inc. for $225 million in an all-cash deal aimed at bolstering Cephalon's lineup of cancer treatments.
Drugmakers Merck & Co. and Sanofi-Aventis SA on abandoned a year-old effort to create a veterinary medicine joint venture because of the deal's mounting complexity and regulatory hurdles.
A paper detailing an important discovery in Niemann-Pick Type C shows how use of a histone deacetylase inhibitor corrects the damage done by the genetic disorder and allows once-diseased cells to function normally.
A daily dose of safflower oil, a common cooking oil, for 16 weeks can improve such health measures as good cholesterol, blood sugar, insulin sensitivity and inflammation in obese postmenopausal women who have Type 2 diabetes.
A long term study reports about the effectiveness of replacing bone marrow, purposely destroyed by chemotherapy, with autologous stem cell rescue for people with aggressive forms of multiple sclerosis.
Scientists have developed a new method for studying gene regulation. By employing a jumping gene as an informant, researchers can systematically explore the very large part of our genome that does not code for proteins.
For a patient at high risk of cardiovascular disease, keeping up with what pills to take at different times of the day can be tedious. Many people, especially the elderly, often forget doses or take the wrong pill at the wrong time.
A software package designed to minimize the potential risks of synthetic biology for the nation's defense and security is now available to the gene synthesis industry and synthetic biology community in an open-source format.
According to a new study, eElderly patients prescribed combination angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARB) had a higher risk of kidney failure and death.
Dionex has released three MAbPac SCX-10 column formats for faster MAb analysis, pH gradients, and LC/MS use. The MAbPac SCX-10 is designed specifically for high-resolution analysis and characterization of MAb variants.
Agilent Technologies, Inc. introduced the Agilent 971-FP Flash Purification System, a personal flash chromatography instrument for pharmaceutical chemists, offering fast, easy, and secure purification of new synthetic compounds.